| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c25ba6f9cd09a022781b8a28dc9081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-487 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2018-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bfec11b5c6499e248778454e4a6d54d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88263c31a3cb70838e5d11636a4cd1ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d0e25b97a8a3b0149eec7622ad8bb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d4397ed81b499255722df681109f7f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d320ac863f9af09fbe67879b36d0d1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac1db3a8bb9d594fcf39293999f852f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8507872bce8229e970f398821a16695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40aaaad7080ac9cdd5c0e4f8c6aa5d09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbbeaa9692a664d66a8a9a66c06d78af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8908f4f080621b538edafbb1fe4cdec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3684f2ec06b30c45c0897e70a8cfb141 |
| publicationDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019036715-A1 |
| titleOfInvention |
METHODS OF TESTING SENSITIVITY TO ANTIMICROBIAL AGENTS |
| abstract |
A method for determining the susceptibility of bacteria present in a clinical specimen, including urine or inoculation thereof, to an antibiotic agent, which may include the steps of: a) inoculating a test portion of the clinical specimen in a medium containing a predetermined concentration of the antibiotic agent; b) inoculating a control portion of the clinical sample in a medium that does not contain the antibiotic agent; c) incubate the test portion for a certain incubation period; d) incubate the control portion during the incubation period; e) determine the amount of RNA present in the test portion and the amount of RNA present in the control portion at the end of the incubation period that does not exceed 480 minutes after completion of the test portion; step a); and f) determining the susceptibility of the bacteria to the antibiotic agent by comparing the amount of RNA present in the test portion with the amount of RNA present in the control portion. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021021782-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11441167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019222227-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021099499-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4004227-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3794150-A4 |
| priorityDate |
2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |